Royal Bank of Canada
ATXI

Royal Bank of Canada’s Avenue Therapeutics, Inc. Common Stock ATXI Stock Holding History

Royal Bank of Canada’s Portfolio ATXI Stock Details ATXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-8
Closed – – 7625
2024
Q2 		$0 Buy
8
+1
+14% +$6 ﹤0.01% 7658
2024
Q1 		$0 Hold
7
– – ﹤0.01% 7731
2023
Q4 		$0 Buy
7
+6
+600% +$140 ﹤0.01% 7694
2023
Q3 		$0 Hold
1
– – ﹤0.01% 7719
2023
Q2 		$0 Hold
1
– – ﹤0.01% 7753
2023
Q1 		$0 Hold
1
– – ﹤0.01% 7595
2022
Q4 		$0 Buy
+1
New +$181 ﹤0.01% 7841
2022
Q3 		– Hold
0
– – – 7975
2022
Q2 		– Hold
0
– – – 7807
2022
Q1 		– Hold
0
– – – 8103
2021
Q4 		– Hold
0
– – – 7957
2021
Q3 		– Sell
-1
Closed -$2.07K – 7933
2021
Q2 		$3K Hold
1
– – ﹤0.01% 7196
2021
Q1 		$5K Hold
1
– – ﹤0.01% 7059
2020
Q4 		$4K Sell
1
-1
-50% -$5.24K ﹤0.01% 6756
2020
Q3 		$23K Hold
2
– – ﹤0.01% 5650
2020
Q2 		$23K Buy
+2
New +$22.6K ﹤0.01% 5544
2020
Q1 		– Hold
0
– – – 7107
2019
Q4 		– Hold
0
– – – 6704
2019
Q3 		– Hold
0
– – – 6537
2018
Q4 		– Hold
0
– – – 7195
2018
Q3 		– Hold
0
– – – 7001

Other funds holding ATXI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
MAWA
Moss Adams Wealth Advisors Seattle, Washington $1.6B AUM 28.24% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Royal Bank of Canada's ATXI Position: Q3 2024 in Review

Royal Bank of Canada sold out of Avenue Therapeutics, Inc. Common Stock (ATXI) in Q3 2024, closing a stake of 8 shares.

Royal Bank of Canada first reported a position in ATXI in Q2 2020 and held it in 12 quarters. The position peaked at $23K in Q3 2020. 8 funds tracked by Wall St. Rank hold ATXI as of Q3 2024.

  • Royal Bank of Canada reported no remaining Avenue Therapeutics, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Royal Bank of Canada sold 8 Avenue Therapeutics, Inc. Common Stock shares in Q3 2024.
  • Royal Bank of Canada first reported a position in Avenue Therapeutics, Inc. Common Stock in Q2 2020 and held it in 12 quarters.
  • Royal Bank of Canada's Avenue Therapeutics, Inc. Common Stock position peaked at $23K in Q3 2020.
  • 8 funds tracked by Wall St. Rank held Avenue Therapeutics, Inc. Common Stock as of Q3 2024.

Based on Royal Bank of Canada's 13F filing for Q3 2024, filed 14 Nov 2024.